Fundraising FoxSUTROVAX, INC.
NASDAQ: PCVXSouth San Francisco, US · Founded 2013 · 11 known investors
Find your way into SUTROVAX, INC.
Sign up to see every warm intro you have to SUTROVAX, INC.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SUTROVAX, INC. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases. The company is led by experienced vaccinologists and pharma industry veterans.
Founders & leadership
SUTROVAX, INC. was founded in 2013 by Grant Pickering and Jeff Fairman.
Board
Investors · 11
How we know: board seat on SEC Form D · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: the S-1 prospectus · board seat on SEC Form D · Not right? Tell us
How we know: the S-1 prospectus · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: the S-1 prospectus · board seat on SEC Form D · funding news · Not right? Tell us
How we know: the S-1 prospectus · board seat on SEC Form D · funding news · Not right? Tell us
How we know: the S-1 prospectus · funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$205.9M disclosed across 4 rounds · 2015–2020
▶$110MraisedApr 2020 · 23 investors · BiotechnologyRule 506(b)
- Jeff FairmanExecutive Officer
- William NewellDirector
- Rob HopfnerDirector
- Kurt von EmsterDirector
- Peter HirthDirector
- Jane Wright-MitchellExecutive Officer
- Moncef SlaouiDirector
- James P WassilExecutive Officer
- Patrick EnrightDirector
- Grant E PickeringExecutive Officer, Director
- Patrick J HeronDirector
- Heath LukatchDirector
- Offering amount
- $110M
- Amount sold
- $110M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$43.2MraisedJun 2018 · 12 investors · BiotechnologyRule 506(b)
- William J NewellDirector
- Peter HirthDirector
- Durga P BobbaExecutive Officer
- Elaine SunExecutive Officer
- Jeff FairmanExecutive Officer
- Grant E PickeringExecutive Officer, Director
- Moncef SlaouiDirector
- Heath LukatchDirector
- Kurt von EmsterDirector
- Patrick HeronDirector
- Rob HopfnerDirector
- Patrick EnrightDirector
- Offering amount
- $85.7M
- Amount sold
- $43.2M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$40.1MraisedMar 2017 · 9 investors · BiotechnologyRule 506(b)
- Kurt von EmsterDirector
- Patrick EnrightDirector
- Elaine SunExecutive Officer
- Peter HirthDirector
- Grant PickeringExecutive Officer, Director
- Patrick HeronDirector
- Jeff FairmanExecutive Officer
- Ashish KhannaExecutive Officer
- Tracy SaxtonDirector
- William NewellDirector
- Offering amount
- $60.2M
- Amount sold
- $40.1M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$12.6MraisedJul 2015 · 7 investors · BiotechnologyRule 506(b)
- Tracy SaxtonDirector
- Grant E PickeringExecutive Officer, Director, Promoter
- Jeff FairmanExecutive Officer
- Ashish KhannaExecutive Officer
- William NewellDirector
- Kurt von EmsterDirector
- Patrick EnrightDirector
- Offering amount
- $26.9M
- Amount sold
- $12.6M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $196.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does SUTROVAX, INC. do?
- Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases. The company is led by experienced vaccinologists and pharma industry veterans.
- Who founded SUTROVAX, INC.?
- SUTROVAX, INC. was founded by Grant Pickering, Jeff Fairman in 2013.
- Who are SUTROVAX, INC.'s investors?
- SUTROVAX, INC.'s investors include Abingworth, CTI Life Sciences Fund L.P., Foresite Capital, Frazier Life Sciences, Janus Henderson Investors, Longitude Capital, Medicxi, Pivotal Life Sciences and 3 more.
- How much funding has SUTROVAX, INC. raised?
- SUTROVAX, INC. has disclosed $205.9M raised across 4 rounds.
- Where is SUTROVAX, INC. headquartered?
- SUTROVAX, INC. is headquartered in South San Francisco, US.